The Swiss attorney general is eyeing the $1.2 million deal that Novartis made with Michael Cohen, President Trump’s personal lawyer, but is not conducting any criminal probe at this time, according to a statement from the federal prosecutor.

As reported last week, Cohen approached Novartis in early 2017 to offer access to the new Trump administration. And Joe Jimenez, who was chief executive officer at the drug maker at the time, agreed to a one-year, $1.2 million contract, even though Cohen is not a registered lobbyist or an expert in health care policy.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!


What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy